Symphogen
Showing 1 - 16 of 16
Malignant Glioma Trial in Durham (Sym004 - 18 mg/kg, Sym004 - 24 mg/kg)
Completed
- Malignant Glioma
- Sym004 - 18 mg/kg
- Sym004 - 24 mg/kg
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center
Jul 23, 2020
Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)
Active, not recruiting
- Metastatic Cancer
- Solid Tumor
- Sym021
- +3 more
-
Aurora, Colorado
- +17 more
Sep 8, 2022
Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma Trial in Worldwide (Sym004, Futuximab, Modotuximab)
Terminated
- Metastatic Colorectal Cancer
- +2 more
- Sym004
- +2 more
-
Duarte, California
- +17 more
Sep 7, 2020
Carcinoma, Squamous Cell of Head and Neck Trial in Belgium, France, Germany (Sym004)
Completed
- Carcinoma, Squamous Cell of Head and Neck
-
Antwerp, Edegem, Belgium
- +9 more
Sep 13, 2018
Metastatic Colorectal Cancer Trial in Spain, United States (Sym004, FOLFIRI)
Terminated
- Metastatic Colorectal Cancer
-
Los Angeles, California
- +7 more
Mar 14, 2019
Metastatic Colorectal Cancer Trial in Worldwide (Sym004 (12 mg/kg), Sym004 (9/6 mg/kg), Best Supportive Care (BSC))
Completed
- Metastatic Colorectal Cancer
- Sym004 (12 mg/kg)
- +4 more
-
Los Angeles, California
- +53 more
Apr 9, 2019